Patent ID: 8293891

Claim:
A compound of formula I in which R 1 denotes H, A, —[C(R 6 ) 2 ] n Ar, —[C(R 6 ) 2 ] n Het or —[C(R 6 ) 2 ] n cycloalkyl, R 2 denotes H or A, R 3 , R 4 each, independently of one another, denote H, A, Hal, CN, —[C(R 6 ) 2 ] n Ar, —[C(R 6 ) 2 ] n Het or —[C(R 6 ) 2 ] n cycloalkyl, R 5 denotes H, A, —[C(R 6 ) 2 ] n Ar, —[C(R 6 ) 2 ] n Het or —[C(R 6 ) 2 ] n cycloalkyl, R 6 denotes H or alkyl having 1-6 C atoms, A, A′ each, independently of one another, denote unbranched or branched alkyl having 1-10 C atoms, in which one or two CH 2 groups may be replaced by O or S atoms and/or by —CH═CH— groups and/or 1-7 H atoms may be replaced by F, Hal denotes F, Cl, Br or I, Ar denotes a saturated, unsaturated or aromatic carbocycle having 5-14 C atoms which is unsubstituted or mono-, di-, tri-, tetra- or pentasubstituted by OH, OA, SH, SA, SOA, SO 2 A, Hal, NO 2 , NH 2 , NHA, NAA', A, SO 2 NH 2 , SO 2 NHA, SO 2 NAA′, CONH 2 , CONHA, CONAA', NACOA', NASO 2 A′, COOH, COOA, COA, CHO and/or CN, Het denotes furyl, thienyl, pyrrolyl, imidazolyl, pyrazolyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyrimidinyl, triazolyl, tetrazolyl, thiadiazole, pyridazinyl, pyrazinyl, indolyl, isoindolyl, benzimidazolyl, indazolyl, quinolyl or 1,3-benzodioxolyl, each of which is unsubstituted or mono- or disubstituted by OH, OA, Hal and/or A, and n denotes 0, 1 or 2, or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof.